| Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, GR Cunha, P Hein, ... Breast Cancer Research 2, 1-1, 2000 | 2031 | 2000 |
| 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes WM Rideout III, GA Coetzee, AF Olumi, PA Jones Science 249 (4974), 1288-1290, 1990 | 855 | 1990 |
| In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation PA Gameiro, J Yang, AM Metelo, R Pérez-Carro, R Baker, Z Wang, ... Cell metabolism 17 (3), 372-385, 2013 | 357 | 2013 |
| MR imaging of renal masses: correlation with findings at surgery and pathologic analysis I Pedrosa, MR Sun, M Spencer, EM Genega, AF Olumi, WC Dewolf, ... Radiographics 28 (4), 985-1003, 2008 | 345 | 2008 |
| Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder AF Olumi, YC Tsai, PW Nichols, DG Skinner, DR Cain, LI Bender, ... Cancer research 50 (21), 7081-7083, 1990 | 341 | 1990 |
| Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy IF San Francisco, WC DeWOLF, S Rosen, M Upton, AF Olumi The Journal of urology 169 (1), 136-140, 2003 | 252 | 2003 |
| Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism SM Fendt, EL Bell, MA Keibler, SM Davidson, GJ Wirth, B Fiske, ... Cancer research 73 (14), 4429-4438, 2013 | 242 | 2013 |
| Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage CH Spruck III, WM Rideout III, AF Olumi, PF Ohneseit, AS Yang, YC Tsai, ... Cancer research 53 (5), 1162-1166, 1993 | 225 | 1993 |
| pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2 H Yang, YA Minamishima, Q Yan, S Schlisio, BL Ebert, X Zhang, L Zhang, ... Molecular cell 28 (1), 15-27, 2007 | 221 | 2007 |
| Role of chromosome 9 in human bladder cancer N Miyao, YC Tsai, SP Lerner, AF Olumi, CH Spruck III, ... Cancer research 53 (17), 4066-4070, 1993 | 218 | 1993 |
| Metformin use and prostate cancer risk MA Preston, AH Riis, V Ehrenstein, RH Breau, JL Batista, AF Olumi, ... European urology 66 (6), 1012-1020, 2014 | 192 | 2014 |
| Persistent c-FLIP (L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand–mediated apoptosis in prostate cancer X Zhang, TG Jin, H Yang, WC DeWolf, R Khosravi-Far, AF Olumi Cancer research 64 (19), 7086-7091, 2004 | 189 | 2004 |
| Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer AA Aizer, JJ Paly, AL Zietman, PL Nguyen, CJ Beard, SK Rao, ID Kaplan, ... Journal of Clinical Oncology 30 (25), 3071-3076, 2012 | 166 | 2012 |
| Personalized medicine for the management of benign prostatic hyperplasia SK Bechis, AG Otsetov, R Ge, AF Olumi The Journal of urology 192 (1), 16-23, 2014 | 165 | 2014 |
| Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations L Li, L Zhang, X Zhang, Q Yan, YA Minamishima, AF Olumi, M Mao, ... Molecular and cellular biology 27 (15), 5381-5392, 2007 | 134 | 2007 |
| Primary spermatic cord tumors: disease characteristics, prognostic factors, and treatment outcomes D Rodríguez, GW Barrisford, A Sanchez, MA Preston, EI Kreydin, ... Urologic Oncology: Seminars and Original Investigations 32 (1), 52. e19-52. e25, 2014 | 113 | 2014 |
| MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP (L) W Li, X Zhang, AF Olumi Cancer research 67 (5), 2247-2255, 2007 | 113 | 2007 |
| The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection JO Ung, IF San Francisco, MM Regan, WC DeWOLF, AF Olumi The Journal of urology 169 (1), 130-135, 2003 | 112 | 2003 |
| Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system F Dong, C Wang, AB Farris, S Wu, H Lee, AF Olumi, WS McDougal, ... The American journal of surgical pathology 36 (6), 838-843, 2012 | 110 | 2012 |
| c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells X Zhang, L Zhang, H Yang, X Huang, H Otu, TA Libermann, WC DeWolf, ... Cancer research 67 (19), 9425-9434, 2007 | 101 | 2007 |
